Arya Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -13.34%
- Profit Growth -57.56%
- Ebitda 27.97%
- Net Worth 16.57%
- Total Assets 7.42%
About Arya Remedies
Arya Remedies Private Limited (ARPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 May 2008 and has a history of 16 years and eight months. Its registered office is in Patna, Bihar, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ranvijay Arya, Pushpa Devi, Rajesh Arya, and One other member serve as directors at the Company.
Company Details
-
Location
Patna, Bihar, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85191BR2008PTC013680
-
Company No.
013680
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 May 2008
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Arya Remedies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Arya
|
Managing Director | 28-Oct-2010 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Ranvijay Arya
|
Director | 30-May-2008 | Current |
|
Pushpa Devi
|
Director | 30-May-2008 | Current |
|
Ranjeet Arya
|
Director | 28-Oct-2010 | Current |
Financial Performance of Arya Remedies.
Arya Remedies Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.34% decrease. The company also saw a substantial fall in profitability, with a 57.56% decrease in profit. The company's net worth Soared by an impressive increase of 16.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arya Remedies?
In 2023, Arya Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Arya Remedies?
Unlock and access historical data on people associated with Arya Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arya Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arya Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.